4//SEC Filing
Naftzger J. Christopher 4
Accession 0001447028-25-000037
CIK 0001447028other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:02 PM ET
Size
335.0 KB
Accession
0001447028-25-000037
Insider Transaction Report
Form 4
Naftzger J. Christopher
General Counsel and CCO
Transactions
- Sale
Common Shares
2025-02-04$3.28/sh−11,333$37,206→ 86,244 total
Footnotes (2)
- [F1]Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on July 11, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of previous grants of restricted stock units.
- [F2]Includes 1,214 and 1,263 shares acquired under the Arbutus Biopharma Corporation 2020 Employee Stock Purchase Plan on February 29, 2024 and August 30, 2024, respectively.
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeother
Related Parties
1- filerCIK 0001496194
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:02 PM ET
- Size
- 335.0 KB